Company Growth (employees)
AbbVie was founded in 2013 and is headquartered in North Chicago, US
Key People at AbbVie
Richard A. Gonzalez
Chairman of the Board and Chief Executive Officer
AbbVie Office Locations
AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd
AbbVie Data and Metrics
AbbVie Financial Metrics
AbbVie's revenue was reported to be $25.6 b in FY, 2016 which is a 12% increase from the previous period.
USD
Revenue (FY, 2016) | 25.6 b |
Revenue growth (FY, 2015 - FY, 2016), % | 12% |
Gross profit (FY, 2016) | 19.8 b |
Gross profit margin (FY, 2016), % | 77% |
Net income (FY, 2016) | 6 b |
Market capitalization (17-Aug-2017) | 111.8 b |
Cash (31-Dec-2016) | 5.1 b |
EV | 143.5 b |
AbbVie's current market capitalization is $111.8 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 18.8 b | 20 b | 22.9 b | 25.6 b |
Revenue growth, % | 6% | 15% | 12% | |
Cost of goods sold | 4.6 b | 4.4 b | 4.5 b | 5.8 b |
Gross profit | 14.2 b | 15.5 b | 18.4 b | 19.8 b |
Gross profit Margin, % | 76% | 78% | 80% | 77% |
Operating expense total | 13.1 b | 16.5 b | 15.3 b | 16.3 b |
Interest expense | (278 m) | (391 m) | (686 m) | (965 m) |
Income tax expense | 1.2 b | 595 m | 1.5 b | 1.9 b |
Net Income | 4.1 b | 1.8 b | 5.1 b | 6 b |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 9.6 b | 8.3 b | 8.4 b | 5.1 b |
Accounts Receivable | 3.9 b | 3.7 b | 4.7 b | 4.8 b |
Inventories | 1.2 b | 1.1 b | 1.7 b | 1.4 b |
Current Assets | 17.8 b | 16.1 b | 16.3 b | 16.2 b |
PP&E | 2.3 b | 2.5 b | 2.6 b | 2.6 b |
Goodwill | 6.3 b | 5.9 b | 13.2 b | 15.4 b |
Total Assets | 29.2 b | 27.5 b | 53.1 b | 66.1 b |
Total Debt | 3.9 b | 4.3 b | 29.6 b | 36.8 b |
Current Liabilities | 6.9 b | 11.4 b | 10.9 b | 9.8 b |
Additional Paid-in Capital | 3.7 b | 4.2 b | 13.1 b | 13.7 b |
Retained Earnings | 1.6 b | 535 m | 2.2 b | 4.4 b |
Total Equity | 4.5 b | 1.7 b | 3.9 b | 4.6 b |
Debt to Equity Ratio | 0.9 x | 2.4 x | 7.5 x | 7.9 x |
Debt to Assets Ratio | 0.1 x | 0.2 x | 0.6 x | 0.6 x |
Financial Leverage | 6.5 x | 15.8 x | 13.4 x | 14.3 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 4.1 b | 1.8 b | 5.1 b | 6 b |
Accounts Receivable | 681 m | (172 m) | (1.1 b) | (71 m) |
Inventories | (56 m) | (203 m) | (434 m) | (38 m) |
Accounts Payable | (426 m) | (193 m) | 1.5 b | (1.2 b) |
Cash From Operating Activities | 6.3 b | 3.5 b | 7.5 b | 7 b |
Cash From Investing Activities | 879 m | (926 m) | (12.9 b) | (6.1 b) |
Short-term Borrowings | (601 m) | 12 m | (19 m) | (29 m) |
Dividends Paid | (2.6 b) | (2.7 b) | (3.3 b) | (3.7 b) |
Cash From Financing Activities | (3.4 b) | (3.3 b) | 5.8 b | (3.9 b) |
Income Taxes Paid | 1.3 b | 498 m | 1.1 b | 3.6 b |
| USD | Y, 2016 |
|---|---|
EV/CFO | 20.4 x |
Revenue/Employee | 1 m |
Debt/Equity | 7.9 x |
Debt/Assets | 0.6 x |
Financial Leverage | 14.3 x |
AbbVie Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Stem CentRx | April 28, 2016 | $5.8 b |
AbbVie Market Value History
AbbVie Median Salaries
Source: 442 public H-1B filings from AbbVie
Market Position of AbbVie
Traffic Overview of AbbVie
AbbVie Online and Social Media Presence
AbbVie News and Updates
August 05, 2016
Elliott Associates sues AbbVie over failed bid for Shire
Aug 5 (Reuters) - AbbVie Inc said hedge fund
Elliott Associates LP has sued the pharmaceuticals company
alleging that it had made misrepresentations and omissions
related to a failed attempt to buy Dublin-based Shire Plc
.
July 15, 2016
Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
Copycats of AbbVie's Humira and Amgen's Enbrel may soon win FDA approval.